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Many young patients with systemic hypertension have secondary causes which if identified early could lessen the
cardiovascular complications associated with long standing hypertension. Coarctation of the aorta is one of those rare
causes. We describe a 40 year old male with hypertension, coarctation of the aorta, bicuspid aortic valve, PDA and an
adrenal mass.
 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Keywords: Coarctation of the aorta, Adrenal mass, PheochromocytomaEssential systemic hypertension can affectyoung adults, but many have secondary
causes most frequently due to chronic renal or
renovascular disease.
Coarctation of the aorta is a rare cause of sys-
temic hypertension. Most people with untreated
aortic coarctation die young before the age of 50
years, due to severe cardiovascular complications.
Though the association of adrenal mass and or
pheochromocytoma have been previously
reported in literature [1], this to our knowledge
is the first in our community.
We describe a male patient 40 years of age
where we diagnosed congenital cardiovascular
disease and a rare association. We also reviewed
the literature on this anomaly and its associations.Case report
A 40 year old man was referred to the cardiology
clinic at KAMC-Jeddah for further treatment and
evaluation of long standing hypertension which
was diagnosed at the young age of 32. The patient1016–7315  2011 King Saud University.
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doi:10.1016/j.jsha.2011.10.007was complaining of occasional headaches. He de-
nied episodic palpitations, diaphoresis, facial
flushing and weight loss. He also denied history
of intermittent claudication. His treatment con-
sisted of amlodipine 10 mg, indapamide 1.5 mg
and lisiopril 10 mg daily.
On physical examination, he was well looking,
there was no dysmorphic features. Blood pressure
in the right arm was 153/78 with no difference
from the left upper extremity.
There was more than 40 mmHg systolic gradient
between the upper and the lower extremities.
His radial pulse was strong at a rate of 78 b/m
with bilateral weak femoral pulses and significant
radio-femoral delay. The cardiac auscultation re-
vealed normal first heart sound loud second heart
sound ejection click and diamond shaped systolic
murmur 2/6 best heard in the L parasternal and
interscapular region.
The electrocardiogram showed sinus rhythm
with LVH by voltage criteria. Renal function and
electrolytes were normal. Chest X-ray showed
normal cardiac silhouette, rib erosions were not
Figure 2. Volume rendering 3 D reconstruction showing the site of the
coarctation.
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left ventricular function, concentric LVH, bicuspid
aortic valve with mild stenosis (AVA OF 1.8 cm2
and mean gradient of 22 mmHg).
Suprasternal window confirmed the presence of
coarctation with 57 mmHg pressure gradient
across it (Fig. 1). (Hemodynamically significant)
no other anomalies noted.
Aortic CT angiogram not only confirmed the
diagnoses (Fig. 2) but also showed an incidental
finding of right adrenal mass of 3.7  5.2 cm con-
firmed by CT abdomen (Fig. 3) suggesting possi-
ble coexistence of phoechromocytoma.
Full endocrionological assays excluded Cushing
and pheochromocytoma.
The patient treatment was modified indapamide
was discontinued labetalol 200 mg twice daily was
added together with Lipitor 40 mg.
The patient underwent laparoscopic right adre-
nalectomy due to a large sized mass. Histopathol-
ogy of the mass showed cystic changes with
calcification there was no malignancy.
Cath lap angiographic study showed atretic
PDA at the site of the coarctation (Fig. 4). He
underwent successful covered stent placement at
KAMC-Riyadh that closed the PDA and opened
up the coarctation segment. Follow up aortic CT
angiogram confirmed patency of the stent, shrink-
age of the size of the collaterals and absence of
stent related complications (Fig. 5).
We were able to decrease his antihypertensive
medication to atenolol 50 mg daily and lisiopril
10 mg daily in addition to Lipitor and aspirin.Figure 1. Suprasternal notch window showing flow turbulence in the des
(significant more than 20 mmHg).He however will be followed up regularly with
yearly echocardiogram to monitor progression of
his bicuspid aortic valve stenosis as well as assess-
ment of the need of further stent dilatation. He
likely would require aortic valve surgery in the
future.cending aorta and flow acceleration with a gradient of 57–54 mmHg
Figure 3. CT abdomen showing large right adrenal mass with
calcification.
Figure 4. LAO aortic root angiogram showing the coarctation and the
PDA (a).
Figure 5. Showing the stent at the site of the coarctation (under
expanded) there was no significant gradient following deployment.
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Native coarctation of the aorta has the preva-
lence of 5–8% [2] this involves stenosis of the distal
part of the aortic arch after the bifurcation of the
left subclavian artery at the level of the ductus
arteriosus, resulting in raised blood pressure at
the upper limbs.
Isolated coarctation is slightly more common in
males than females, especially in older patients.
It is frequently associated with other congenital
defects and as many as 50–80% will have a bicus-
pid aortic valve [3]. Other cardiac defects areabnormalities of the mitral valve (prolapsed and
stenosis), patent ductus arteriosus, a ventricular
septal defect, endocardialendoelastosis. Non car-
diac association includes the presence of cerebral
aneurysms in the circle of willis. Hypospadias,
club foot, ocular defect and pheochromocytoma.
Coarctation is the most common congenital defect
in patients who have XO turner’s syndrome.
Coarctation of the aorta classically produces
symptoms at two stages of life, in early infancy
and in the second and third decades [4]. Symp-
toms develop in infancy in only approximately
10% of all patients with an uncomplicated coarcta-
tion and they are related to proximal aortic hyper-
tension and under perfusion of the distal aorta.
Symptoms usually remain minimal until the sec-
ond or third decade of life, when the ravages of
prolonged hypertension become manifest and
associated complications emerge. Rupture of the
aorta or dissecting aneurysm is most commonly
seen in the third and fourth decades of life [5].
Infective endocarditis also becomes a more seri-
ous complication with age [6], often affecting the
associated bicuspid aortic valve. Similarly, rupture
of an aneurysm of the circle of Willis is more evi-
dent later in life and is not always related to the
presence of hypertension [7]. Premature coronary
artery disease may also occur [8]. Ideally aortic
coarctation should be detected during early
infancy by routine physical examination of upper
and lower-extremity pulses. Although most peo-
ple with systemic hypertension have essential
hypertension, aortic coarctation still remains a
very rare (0.2% of hypertensive subjects [9]) but
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diagnosed and treated in early life.
Prognosis of an unrepaired coarctation is very
unfavorable. Approximately 25% die between 20
and 50 years of age, while 90% of the original
group dies before 50 years of age. Another 5%
die at 50–60 years and the remaining 5% die at still
older age [6,4].
In children and adults, coarctation should be cor-
rected electively when the diagnosis is made,
regardless of acquired complications. Most authors
believe that children with uncomplicated asymp-
tomatic coarctation are best operated between age
3 and 5 years, when operative risk is low and the
incidence of postoperative complications is accept-
able [8]. An increased preoperative mortality in cor-
rections performed in patients older than age 40
years has been reported [10]. The incidence of
residual postoperative complications, i.e., persis-
tent hypertension, paraplegia, and mesenteric
arthritis, is higher in these older patients [10]. How-
ever, in the absence of precluding medical prob-
lems, age alone is not a contraindication to repair.
Correction after the age of 5 years results in a con-
siderable risk for persistent hypertension, espe-
cially exercise-induced hypertension [11]. When
operation is performed under 2 years of age there
is an increased risk for recoarctation [12]. Surgical
repair has been the standard therapy for coarcta-
tion since its introduction in 1945 [13]. A variety of
surgical approaches can be used, including resec-
tion and end-to-end anastomosis, the use of the left
subclavian artery as a patch, or a Dacron patch.
Although there are some reports of surgical treat-
ment with good outcome [14,15], even in combined
surgery with CABG [16], it still remains a very high
risk intervention that must be weighed against the
benefit of prolonging a patient’s survival and ame-
liorating a patient’s clinical symptoms.
Balloon angioplasty for the correction of aortic
coarctation was first introduced in 1982. Many
now recommend this technique as an alternative
for surgery or recoarctation of previously operated
coarctation [17,18]. Some extend this preference to
the unoperated or native coarctation [19–22].
Nowadays Stent implantation is considered the
therapy of first choice for aortic coarctation in
adults [23–25]. The advantages of this method
have extended its use to adolescents and children
[26] and in some centers even to small infants.Conclusion
Young patient have essential hypertension, but
many have secondary causes, every effort has tobe exhausted to excluded secondary causes. This
case highlights the importance of thorough phys-
ical examination as it did reveal the diagnosis.
We think the adrenal mass presence is just an
incidental finding.References
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